688P Gene expression profiling (GEP) signatures associated with markers of sensitivity to immune and angiogenic therapy in clear-cell renal cell carcinoma (ccRCC) with sarcomatoid/rhabdoid features
Publication
, Conference
Coelho Barata, PM; Gulati, S; Elliott, A; Rao, A; Burgess, EF; McKay, R; Hammers, HJ; Gartrell, B; Darabi, S; Bilen, MA; Geynisman, D; Wei, S ...
Published in: Annals of Oncology
September 2021
Duke Scholars
Published In
Annals of Oncology
DOI
ISSN
0923-7534
Publication Date
September 2021
Volume
32
Start / End Page
S705 / S705
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Coelho Barata, P. M., Gulati, S., Elliott, A., Rao, A., Burgess, E. F., McKay, R., … Heath, E. (2021). 688P Gene expression profiling (GEP) signatures associated with markers of sensitivity to immune and angiogenic therapy in clear-cell renal cell carcinoma (ccRCC) with sarcomatoid/rhabdoid features. In Annals of Oncology (Vol. 32, pp. S705–S705). Elsevier BV. https://doi.org/10.1016/j.annonc.2021.08.084
Coelho Barata, P. M., S. Gulati, A. Elliott, A. Rao, E. F. Burgess, R. McKay, H. J. Hammers, et al. “688P Gene expression profiling (GEP) signatures associated with markers of sensitivity to immune and angiogenic therapy in clear-cell renal cell carcinoma (ccRCC) with sarcomatoid/rhabdoid features.” In Annals of Oncology, 32:S705–S705. Elsevier BV, 2021. https://doi.org/10.1016/j.annonc.2021.08.084.
Coelho Barata PM, Gulati S, Elliott A, Rao A, Burgess EF, McKay R, et al. 688P Gene expression profiling (GEP) signatures associated with markers of sensitivity to immune and angiogenic therapy in clear-cell renal cell carcinoma (ccRCC) with sarcomatoid/rhabdoid features. In: Annals of Oncology. Elsevier BV; 2021. p. S705–S705.
Coelho Barata, P. M., et al. “688P Gene expression profiling (GEP) signatures associated with markers of sensitivity to immune and angiogenic therapy in clear-cell renal cell carcinoma (ccRCC) with sarcomatoid/rhabdoid features.” Annals of Oncology, vol. 32, Elsevier BV, 2021, pp. S705–S705. Crossref, doi:10.1016/j.annonc.2021.08.084.
Coelho Barata PM, Gulati S, Elliott A, Rao A, Burgess EF, McKay R, Hammers HJ, Gartrell B, Darabi S, Bilen MA, Geynisman D, Dawson NA, Poorman K, Zibelman M, Zhang T, Wei S, Korn WM, Nabhan C, Ryan CJ, Heath E. 688P Gene expression profiling (GEP) signatures associated with markers of sensitivity to immune and angiogenic therapy in clear-cell renal cell carcinoma (ccRCC) with sarcomatoid/rhabdoid features. Annals of Oncology. Elsevier BV; 2021. p. S705–S705.
Published In
Annals of Oncology
DOI
ISSN
0923-7534
Publication Date
September 2021
Volume
32
Start / End Page
S705 / S705
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis